Waters (WAT) Stock Forecast & Price Target

$368.16 +7.53 (+2.09%)

(As of 12/20/2024 05:31 PM ET)

Waters - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 14 Analyst Ratings

Sell
1

Hold
9

Buy
4

Based on 14 Wall Street analysts who have issued ratings for Waters in the last 12 months, the stock has a consensus rating of "Hold." Out of the 14 analysts, 1 has given a sell rating, 9 have given a hold rating, 3 have given a buy rating, and 1 has given a strong buy rating for WAT.

Consensus Price Target

$375.85
2.09% Upside

According to the 14 analysts' twelve-month price targets for Waters, the average price target is $375.85. The highest price target for WAT is $430.00, while the lowest price target for WAT is $312.00. The average price target represents a forecasted upside of 2.09% from the current price of $368.16.

Get the Latest News and Ratings for WAT and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Waters and its competitors.

WAT Analyst Ratings Over Time

Type	Current Forecast 12/23/23 to 12/22/24	1 Month Ago 11/23/23 to 11/22/24	3 Months Ago 9/24/23 to 9/23/24	1 Year Ago 12/23/22 to 12/23/23
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	3 Buy rating(s)	3 Buy rating(s)	2 Buy rating(s)	0 Buy rating(s)
Hold	9 Hold rating(s)	10 Hold rating(s)	11 Hold rating(s)	8 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$375.85	$365.85	$318.50	$287.78
Forecasted Upside	2.09% Upside	-2.04% Downside	-6.24% Downside	-12.73% Downside
Consensus Rating	Hold	Hold	Hold	Reduce

This is the worst sign for the U.S. stock market in 50 years (Ad)

The Dow recently posted its worst losing streak since 1974. And one of America's most accurate analysts now says this is just the beginning of a new crisis that could be worse than the COVID crash, the dot-com crash, and even the Great Depression. Introducing "The Dead Zone"

Click here to see Dan's new, urgent warning about the U.S. market for 2025.

WAT Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

WAT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Waters Stock vs. The Competition

Type	Waters	Medical Companies	S&P 500
Consensus Rating Score	2.29	2.81	2.51
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	2.09% Upside	25,827.32% Upside	14.53% Upside
News Sentiment Rating	Neutral News See Recent WAT News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/13/2024	Bank of America 3 of 5 stars		Boost Target	Neutral ➝ Neutral	$400.00 ➝ $430.00	+14.29%
11/4/2024	Deutsche Bank Aktiengesellschaft 3 of 5 stars		Boost Target	Hold ➝ Hold	$310.00 ➝ $325.00	-15.59%
11/4/2024	TD Cowen 5 of 5 stars		Boost Target	Hold ➝ Hold	$363.00 ➝ $410.00	+6.73%
11/4/2024	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Market Perform ➝ Market Perform	$345.00 ➝ $360.00	-6.29%
11/4/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$332.00 ➝ $360.00	-7.00%
11/4/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$340.00 ➝ $380.00	-2.10%
This is the worst sign for the U.S. stock market in 50 years (Ad) The Dow recently posted its worst losing streak since 1974. And one of America's most accurate analysts now says this is just the beginning of a new crisis that could be worse than the COVID crash, the dot-com crash, and even the Great Depression. Introducing "The Dead Zone" Click here to see Dan's new, urgent warning about the U.S. market for 2025.
11/4/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Couillard Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$380.00 ➝ $415.00	+7.51%
11/4/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Underweight ➝ Underweight	$330.00 ➝ $360.00	-7.03%
10/17/2024	Cfra Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jonathan Sakraida Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target		$389.00	+10.50%
10/8/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$355.00 ➝ $415.00	+18.60%
10/1/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	In-Line ➝ In-Line	$335.00 ➝ $355.00	-0.39%
8/1/2024	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Souda Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
8/1/2024	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Market Perform ➝ Outperform	$325.00 ➝ $375.00	+11.51%
7/31/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Sykes Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
5/8/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$319.00 ➝ $312.00	-4.31%
12/13/2023	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Peer Perform
12/11/2023	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$265.00 ➝ $300.00	+2.69%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 12:27 AM ET.

WAT Forecast - Frequently Asked Questions

: According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Waters is $375.85, with a high forecast of $430.00 and a low forecast of $312.00.
: 14 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There is currently 1 sell rating, 9 hold ratings, 3 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" WAT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in WAT, but not buy additional shares or sell existing shares.
: According to analysts, Waters's stock has a predicted upside of 2.09% based on their 12-month stock forecasts.
: Over the previous 90 days, Waters's stock had 1 upgrade by analysts.
: Waters has been rated by research analysts at Bank of America, Barclays, Cfra, Deutsche Bank Aktiengesellschaft, Evercore ISI, Jefferies Financial Group, JPMorgan Chase & Co., Sanford C. Bernstein, Stifel Nicolaus, TD Cowen, and Wells Fargo & Company in the past 90 days.
: Analysts like Waters less than other "medical" companies. The consensus rating for Waters is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how WAT compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

This is the worst sign for the U.S. stock market in 50 years (Ad)

Click here to see Dan's new, urgent warning about the U.S. market for 2025.

This page (NYSE:WAT) was last updated on 12/22/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Waters (WAT) Stock Forecast & Price Target